Connectivity White Paper - Tempus

xT CDx: FDA-APPROVED TUMOR + NORMAL ASSAY NOW AVAILABLE TO ORDER /// LEARN MORE xT CDx: FDA-APPROVED TUMOR + NORMAL ASSAY NOW AVAILABLE TO ORDER /// LEARN MORE

Tempus

PROVIDERS
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
LIFE SCIENCES
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
PATIENTS
It's About Time
View the Tempus vision.
RESOURCES
- Resources
- Publications
- Content
- Events
STAY INFORMED
Be notified whenever Tempus publishes new research, webinars, and other resources.
ABOUT US
- About Us
- Our History
- Our Technology
- Our Team
- Careers
- Culture
- News
View Job Postings
We’re looking for people who can change the world.
INVESTORS

ORDER A TEST Log In Contact Us

Download our guide

Harnessing discrete molecular data in the EHR to support precision oncology programs

Thank you.
We will send an email shortly with the link to download our guide.

ORDER A TEST Log In Contact Us

Linkedin Opens a new window
Twitter Opens a new window
YouTube Opens a new window
Instagram Opens a new window

Providers
Oncology
Neurology & Psychiatry
Cardiology
Dermatology
Radiology
Academic & Research Centers
EHR Integration

Life Sciences
Life Sciences Overview
Sequencing
Data Collaborations
Biological Modeling
Companion Diagnostics
Omics Solutions
Clinical Trials Execution
Clinical Trials Enrollment
CRO Services
Care Gap Solutions
- For Oncology
- For Cardiology

Patients
Patients Overview
Oncology
Clinical Trials
Neurology & Psychiatry

Resources
Publications
Content
Events

About Us
Our History
Our Technology
Our Team
Careers
Culture
News

Homepage
Responsible Disclosure
FAQ
Media Library
Document Library
Investors

Homepage
Responsible Disclosure
FAQ
Media Library
Document Library
Investors

Tempus

All Content Copyright 2025| Privacy and Compliance Policies| Terms of Use | Cookie Preferences